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TECHNOLOGY DEVELOPMENT, STANDARDIZATION, AND 
EVALUATION IN PULMONARY MEDICINE 
OVERVIEW 
Technology is playing an ever increasing role in the practice of medicine. 
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This is especially true in neurological, cardiovascular, and pulmonary 
function assessment. New technologies such as imaging techniques with 
computed tomography, sophisticated measurements of hemodynamic and 
respiratory function, along with a better understanding of the pathophysiology 
of pulmonary disease, provide a firmer scientific base on which to make 
clinical judgments. With technological developments, there is additional 
scientific knowledge gained which can aid in diagnosis, prognosis, and 
treatment of patients. The application of computers to assist in the correlation 
and utilization of this data is attractive for 2 reasons; first, the wealth 
of medical knowledge is rapidly expanding, making it difficult to consider 
all of the complexities and factors involved in patient treatment decisions, 
and second, the state-of-the-art of computer technology is advancing rapidly, 
providing increased performance at greatly reduced cost. The trends 
in both the discovery of new medical knowledge and the increase in performance-
to-price ratio of computer technology are likely to continue over the next 
sever a I decades . 
The report of this task group covers a wide variety of subject material 
from recommendations on instrumentation to an ~xpression of the need 
for development of general methods for evaluation of technology. Overall, 
the task group determined that 1) a great need exists for development 
of management methodology for neonates and children; 2) computers could 
be better utilized to acquire, process, store, and utilize data for medical 
decision making; 3) the Intensive Care Unit and Anesthesiology locations 
could be advanced by development of better instrumentation and alarm 
techniques; 4) computers could significantly aid in the evaluation of medical 
images; and 5) the development of reasonable "standards" could be a real 
aid in the development of technology. In addition, it was felt that a cooperative 
relationship should be established between government, industry, and 
clinical users so that innovative technology could be developed and applied 
promptly. Finally, the task group suggests that nof only must new technol-
ogy be evaluated, but the methodology for performing the evaluation also 
needs to be further developed. 
TECHNOLOGY NEEDS OF FETAL, NEONATAL, AND 
PEDIATRIC AGE GROUPS 
INTRODUCTION 
There are three major considerations that make pulmonary data acquisition 
special in pediatric, and particularly neonatal patients. These are: 
l. Special biological considerations: For example, the very flexible 
chest wall may allow phase differences which make ventilation ineffi-
cient, especially with high airway resistance or with decreased 
muscle tone (e.g., REM sleep results in a very flexible chest). 
-r 
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2. Technical difficulties related to patient size: For example, the 
difficulties and hazards of maintaining arterial catheters In infants 
makes other methods of measuring end tidal CO desirable. Many 
methodologies common to the management of res~iratory failure 
in adults cannot be used to treat critically iII neonates and infants. 
3. Problems caused by inability to acquire patient cooperation: The 
single most useful pulmonary function test in adult pulmonary medi-
cine is the forced expiratory spirogram. From this, ventilatory 
parameters, such as maximal midexpiratory flow and timed expiratory 
volumes, can be derived. Unfortunately, few small children and 
no infants can perform the necessary maneuvers. A substitute 
procedure, which is better than a crying vital capacity, is needed. 
Outlined below are some of the more important, and unfulfi lied 
specific technical needs in pediatric pulmonology. 
STATE OF KNOWLEDGE AND TECHNOLOGY 
Minimally Invasive Monitoring to Determine Adequacy of 
Gas Exchange 
Transcutaneous PO 2 and PCO Measurements. The value of this technique in assessment of tfie well pe~used neonate is now established. However, 
the limits of its application, p~rticularly in regard to age and cardiovas-
cular status, are not fully delineated despite the large number of instru-
ments now commercially available. It appears that more research on 
the basic physiology of gas delivery to, and transport through, the 
skin is needed. In addition, this technology still needs more research 
and development in the area of instrument design. Problems of size, 
stability, and speed of response need to be resolved. 
End Tidal CO 2 Monitoring. Although many clinicians and investigators have attempteCI to use th1s monitoring modality, new instrumentation 
with very small volume sample cells and recent theoretical analyses 
of catheter sampling systems have put this technology on a more firm 
foundation for use in infants. Empi rica I studies designed to explore 
limitations of use are now probably worthwhile. 
Ear Oximetry. This method has a great advantage over the transcutaneous 
PO electrode because ..of -its -very ~rapi'd response time. It may also 
-ha-Je advantages in low blood flow states. A practical instrument for 
use on neonates ls .definitely needed. 
Mixed Venous Blood Oxygen Sensor. There is .a need for a mixed 
venous blood oxygen sensor to bring pediatric monitoring up to the 
current capability of adult monitoring. 
II 
Measurement of Tidal Volume 
The measurement of tidal volume in infants on mechanical ventilators 
or during natural breathing is difficult. There are two methods currently 




urement of expired gas flow or volume. The former method, which 
uses magnetometers, suffers from the fact that, at various times, the 
same infant may move different parts of its chest or diaphragm to achieve 
venti fation. For example, during REM sleep, the upper chest often 
decreases in volume during inspiration. This problem is compounded 
in disease where the time constants for gas flow may vary widely over 
the chest. A new device, consisting of an easily distensible, close 
fitting jacket, changes inductance with chest expansion and may sample 
over a wide enough area of the thorax to be practical, but it has not 
been fully tested. It is possible that such a device might be improved 
if fitted with multiple sensors and if appropriate data processing were 
used. 
Measuring flow by using a face mask with a screen pneumotachometer 
has the disadvantage that it has several milliliters of dead space, and 
is very sensitive to the condensation of water. Most other flow measure-
ment devices are either larger or have insufficient dynamic range. 
The recent development of an ultrasonic flowmeter may have application 
in infants. A methOd which is of some use is to introduce a constant 
gas flow under the mask to sweep out the dead space. This bias flow 
is then subtracted electronically. A technology which is totally noninva-
sive and which is potentially accurate in infants is the "barometric 
method" (1-3). However, the limits of Its applicability require further 
evaluation. An easy-to-use, easy-to-calibrate, noninvasive method 
for measuring flow or volume in infants is stiff lacking. 
There is greater hope for development of a device for use when an 
endotracheal tube is already in place. However, there are two remaining 
problems. First, there is the problem of estimating the size of the 
leak around the endotracheal tube as cuffed tubes are not generally 
used in infants. Second, there is the problem of "compressible volume." 
During inspiration, with a mechanical ventilator, gas is compressed 
in the tubing. The compliance of this tubing varies from 0.5 to 5.0 
ml/cm H20 in practical venti fators. In most, if not all, commercially 
available ventilators, the gas exiting via the exhalation valve contains 
true expired gas along with the gas compressed within the system during 
inspiration. Thus, the expired gas is diluted by a farge amount of 
gas of inspiratory composition. This impacts on several areas of inter-
est aside from measurement of tidal volume including: 1) disconnect 
alarms for infant ventilators and anesthesia machines, and 2) high 
frequency ventilation in infants. Modeling studies have shown that 
the volume loss due to compression in the tubing occurs primarily 
·during the stat"t><Of -inspi r.ation, and thus, this phenomenon is most 
.prominent when inspiratory times are very short and would -'be :of 'extra-
ordinary importance during high frequency ventilation. 
Iff 
Measurement nf Fatigue of Respiratory Muscles 
There has been a great deaf of recent work using the power spectrum 
of the diaphragmatic electromyogram (EMG) as an indicator of -respiratory 
muscle fatigue. This is important as muscle fatigue is often the limiting 
factor precipitating frank ventilatory insufficiency and failure. The 
use of this method in small children and infants has many unsolved 
problems, including optimum electrode placement, noise rejection, and 
data processing. Moreover, there is insufficient understanding of 
its physiologic basis . 
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IV 
Measurement of Fetal Breathing 
Several groups of investigators have found that the absence of fetal 
breathing is a good indicator of fetal distress. This is of considerable 
importance from the standpoint of offering a reliable clinical diagnostic 
tool, and also because it may be fetal breathing which, by physically 
affecting venous return, causes short-term heart rate variability. 
The latter is currently used in fetal monitoring. The real-time ultrasonic 
B-scan is used to visualize chest wall motion. Work is needed to develop 
practical instrumentation and to determine the effect of fetal breathing 
on blood flow. 
v 
Measurement of Pulmonary Blood Flow and Shunts 
The potential clinical benefit of measuring pulmonary blood flow in 
infants makes study of new and better techniques necessary. 
VI 
Predictors for SIDS 
Many of the proposed predictors for SIDS are really attributes of popu-
lations postulated to be at increased risk for SIDS. These include 
siblings of infants who have died of SIDS and 11 near miss 11 infants, 
who have had a severe episode of apnea. Such infants have been shown 
to have abnormal heart rates, ventilation, and sleep patterns which 
might be useful as predictors for SIDS. 
VII 
Fiberoptic Devices 
Fiberoptic devices of adequate resolution and of sufficiently small dimen-
sions are commercially available for visualization of the infant's upper 
and lower airways. The problem is that manufacturers- have been unable 
to combine the small size and necessary resglution with an adequate 
channel for suctioning so that in practical situations the view becomes 
obscured by airway secretions. 
VIII 
Alarm Systems -Development for Infant Venti Jators 
and Anesthesia Machines 
-Expi-:red C0 2 ·-monitoring is particularly difficult in infants. There are 
two types of CO monitors. The first has a "flow through11 cell In 
line with the en~otracheal tube. This method has several advantages; 
however, its large volume precludes its use with small infants because 
of dead space considerations. The second method samples gas constantly 
from the airway and the measurement is done in a remote transducer. 
The problem with the second method is that if a sample fJow rate is 
low enough not to deplete the expired gas, the response time may be 
too slow to permit breath by breath analysis. Modeling studies have 
shown that this is -a significant problem with C02 measurements in 




For the foreseeable future, the development of disconnect alarms for 
Infants, especially If one wishes In addition, an assessment of the ade-
quacy of ventilation, Is so complex that a combination of methods Is needed. 
Measurements of pressure, flow, and gas composition may all be needed, 
along with Innovative data processing and display. The anesthesia 
circuit Itself should be reevaluated as It complicates making all of these 
measurements. The solution may lie not In the development of a single 
Instrument, but In the redesign of anesthesia machines. 
NEEDS AND RECOMMENDATIONS 
The development of minimally Invasive measurement techno-
fogies, particularly for measurement of tidal volume and 
ventilatory patterns, should be continued. 
II 
Develop reliable reference methods for this group of patients 
against which less invasive, and more complex devices or techno-
logies can be compared. 
Ill 
The development of better alarm systems for ventl lators and 
anesthe~la machines should be encouraged. 
IV 
The development of measuring systems, small In size with 
very low compliance to allow quantitative study of tidal 
volume and expired gas composition In Infants during mechanical 
ventilation and anesthesia should be fostered. ... 
v 
Reliable methods for the measurement of pulmonary blood 
flow and pulmonary shunting should be developed. 
VI 
Further efforts should be made to Improve flberoptlc 1nstru-
mentatlon for use In Infants. 
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COMPUTER APPLICATIONS IN PULMONARY MEDICINE 
INTRODUCTION 
Computers can assist in improving human productivity. At the same 
time, the capability of computers in terms of computational speed, memory 
costs, and general overall costs has decreased rapidly as the technology 
has developed. Integrated circuit technology, especially with the recent 
innovations in large-scale integration which allows for the development 
of low-cost microprocessors with their associated peripheral equipment, 
has had a dramatic effect on the entire computing field. It is now possible 
to place in a bedside monitoring module a microprocessor, which faci.litates 
computations and noise rejection, which several years ago would have 
required a large computer to implement. Computers are becoming more 
and more Important In the following areas of pulmonary medicine. 
Data Acquisition. By allowing the computer to acquire data from nonlinear 
devices, check data for quality, develop waveform recognition techniques, 
and sharing of data between multiple processors, data can be better 
validated and integrated. 
Data Integration. Utilization of computers for data integration to solve 
the current problem of correlating data from multiple diverse sources 
such as laboratories, ICU's, etc., will permit more prorr.pt and effective 
treatment of patients. 
Data Communications. Utilizing computers to communicate data will 
help solve the problems of slow, unreliable communication which currently 
exist in hospitals. 
One of the major problems remaining to be solved with use of computers 
in clinical medicine is the rr.an/machine interface. A computer interface, 
which will allow for simple interaction with minimal training, h?.s not 
yet been optimized for use by health care professionals. Computer 
terminals and computer software have been simplified to make them 
"user friendly" which is a partial solution to the problem~ However, 
the problem still remains a major challenge for-· computer scientists 
applying computers to medicine. In the next 5 to 10 years, it is anti-
cipated that this problem will be solved and data capture for clinical, 
as well as accounting purposes wi II provide entire clinical and adminis-
trative patient data bases. Once the data are entered into a computer .. 
it serves not only the medical-legal requirements of the medical record, 
but it can also be used for computerized clinical decision-making and 
provide -data for hospital <~dministrative -functions such as billing, produc-
tivity analysis, etc . 
There is a need to establish computer data bases to answer specific 
questions in pulmonary medicine . Limited use of these data bases 
to date has provided valuable insight into types of patient populations. 
Epidemiological studies, for example, require large data bases which 
need to be standardized so that data can be shared between investigators 
looking for effects of environmental factors . Data bases on hazardous 
occupational locations would be very valuable to determine the effects 
of various environmental health hazards. Thus, the establishment 
- -- - ---- ~~ -- - -I -=-=-==-----==--====-=--=-~-=-- - -=-
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of 1) standard techniques, 2) standard equipment (specification), 3) stan-
dard data collection methods, and q) softward documentation, should 
be given high priority. 
STATE OF KNOWLEDGE AND TECHNOLOGY 
Intensive Care Medicine 
See the next section on Technology Needs of Intensive Care and Anesthesi-
ology. 
If 
Data Base Development 
The paralyzing effect of excessive amounts of raw data, particularly 
In the ICU, is becoming increasingly apparent, while the potential for 
use of automation to assist In compressing and evaluating data Is great. 
This potential can only be met if avai fable data are used to develop acceptable 
algorithms to interpret data, and suggest treatments. 
The breadth of data which can be usefully shared for developing such 
decision making algorithms is unlimited . Both long-range outcomes 
and short-term ICU care outcomes are needed. For example, in patients 
with carcinoma of the lung, pooled data on the criteria for resectability--
the useful predictors of cardiopulmonary function and their effect on 
operative and late mortality--would improve the treatment of this disease. 
Criteria for control of ventilator therapy In ICU patients of various 
primary disease categories, I.e., post-cardiac surgery, post-pulmonary 
resection, etc •• would reduce complications, reduce cost, and shorten 
time spent in the ICU. 
To evaluate decision making criteria, outcome goals and data bases must 
be defined. Data bases could then be used to test algorithms during 
their development. Finally, multi-Institutional prospective controlled 
trials could be Instituted to evaluate the usefulness of algorithms using 
a common data base to control the decision logic and assess how well 
outcome criteria have been met. 
ln ·the near future, data 'base sharing and declston algorithm sharing 
will depend on direct cooperation between medical scientists. For more 
general data base and decision making algorithm shadng, data base 
content and outcome criteria will need standardl zatlon. Until now, there 
has been no such standardization. It may be feasible to develop limited 
common data base contents, and outcome criteria which would allow useful 
data sharing. Until such an agreement Is reached, sharing will be of 
limited value. Without such sharing, progress toward development 
of acceptable Interpretive and dedslon algorithms will be slow. The 
utility of modern technology using the capabilities of automation will 
not be realized until such algorithms have been agreed upon, tested, 
and made generally available. 
In addition to data base development for ICU use, there Is a great need 
to develop data bases for other areas of the practice of pulmonary medicine. 
These Include: 
• 
1. The establishment of reference or 11normal" values for pulmonary 
function tests which can be used on a national basis. This wi II 
require standardization of measurement techniques and generation 
of reference values to take into consideration not only the size 
and age of an individual but also race. 
2. Data bases which will aid in the development of a more rational 
determination of the severity of pulmonary disease would be useful. 
For example, the recent work of Epler and associates on the deter-
mination of severity of impairment from lung disease forms a quanti-
tative basis for estimation of disability. Data should be collected 
which will encourage and enhance the ability to quantitate and 
predict the time course of degenerative lung disease. 
3. Data bases of the natural course of pulmonary function parameters 
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in a longitudinal study would aid in understanding the pathophysiology 
of aging of the normal lung and, perhaps, provide insight into 
the effect of environmental factors. 
4. Data bases should be developed and shared which wi II help describe 
the effects of environ mental factors on pulmonary function. 
REFERENCES 
Epler, G. R. , F. A. Saber and E. A. Gaens ler. Determination of severe 
impal nnent (disability) in interstitial lung disease. Am. Rev. Resp. 
Dis. 121: 647-659, 1980. 
Ill 
Computerized Medical Decision Making 
There is need to develop quantitative methods for medical decision 
making, so that computers and computational equipment can be better 
integrated with clinical medicine . Evaluation and management of a 
patient in left ventricular failure is an example of a situation requiring 
integration of data from many sources, including the intensive care 
unit (physiologic hemodynamic monitoring), th~ blood gas laboratory, 
the clinical laboratory, the x-ray department, etc. To make the most 
logical and rational decision in the treatment of a patient, all of this 
data, along with history and physical findings, must be integrated. 
To ,get computers to assist in this kind of decision process, there is 
a necessity to establish quantitative methods and develop algorithms 
for patient treatment. The development of medical -decision logic is 
currently poo.-ly organized i!nd represents _one of the greatest opportunities 
and challenges for the years to come in the application of computer 
technology to medicine. It is surprising how nonquantitative the practice 
of medicine Is. There needs to be developed a mechanism for exchanging 
information on quantitative diagnosis/interpretive methods which will 
facilitate establishment of computer-derived alerting and treatmen_t protocols. 
For example, patient care in the Surgical ICU is becoming increasingly 
complex, both because more difficult operative procedures are being 
attempted, and because the therapeutic armamentarium is enlarging. 
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Therefore, the volume and complexity of data to be interpreted have 
increased. The new complexity is further aggravated by a shortage 
of physicians and nurses trained in critical care. To date, computer 
systems have done little to alleviate these problems; in fact, at times, 
they have con~pounded them by facilitating the collection of increasing 
amounts of data for which medical and nursing teams are ill prepared 
to use . 
On the positive side, however, computer systems have the potential 
to greatly enhance the safety of critical care. The focus of ICU computer 
systems must shift beyond data collection and crisis alarms. Limited 
automated data interpretations have been attempted, but they have typi-
cally required users to enter information before any interpretations 
were made. Thus, instead of prompting action, they have been passive 
responders. 
ICU computers should automatically acquire data for ICU personnel, 
i.e., laboratory data from laboratory information systems, vital signs 
and other pertinent hemodynamic data from bedside instruments, and 
pulmonary function data from tests and bedside monitors. Not all data 
can be directly acquired; fluids and drugs may require entry by the 
nurse. 
With such data, a national cooperative effort should start to develop 
computer consultation and therapeutic control logic to automatically 
provide appropriate advice when data indicate a significant change 
in patient status. While the ultimate goal might be to provide closed 
loop therapy, initially this step is not essential. Useful open loop 
logic can be converted to closed loop after appropriate clinical trials, 
if controllable output devices are available. 
Systems need to be developed based on decision logic which permits 
weighted evaluation of diverse interrelated information. Areas for 
the development of such logic include: 1) optimization of {!Vailable 
oxygen; 2) warning of cardiac tamponade, pneumothorax, and ARDS; 
3) adjustment of preload, afterload, and inotropi"c therapy; 4) optimization 
of CPAP and PEEP levels; 5) management of fluid therapy; and 6) assist-
ance in acid-base and electrolyte management. Without some effective 
prompting, accidents of oversight or misinterpretation will continue. 
If the goals are defined, an automated watchdog of ever .incr-easing 
--capability ·should be able to assist the ICU staff in patient care by prompting 
timely and appropriate action. 
Computerized medical decision making can also be of assistance to a 
general hospital population through simple, but Important, decisions 
which can adequately be made by the computer such as interpretation 
of blood gas results, interpretation -of screening pulmonary function 
tests, the evaluation of the effects of various modes of respiratory therapy, 
and generation of differential diagnosis lists. · 
To allow modifications to medical decision algorithms and to transfer 
this technology between laboratories, detailed software documentation 
is essential. Support for development of medical decision algorithms 
should Include support for software documentation in a manner wh1ch 
is easily understood by other computer specialists. 
·' 
IV 
Use of Microcomputers in Pulmonary Medicine 
A recent (October 17-19, 1979) NIH consensus development conference 
on "The use of microprocessor-based 'Intelligent' machines In patient 
care" was held to explore the opportunities resulting from the development 
of microcomputer (microcircuit) technology which allows tens of thousands 
of transistors and related electronic components to be fit on a one-fourth 
inch square silicon chip. The following is a brief summary of this 
conference . 
1. The general effect of this technology on society wi II go far beyond 
its application to medicine alone. 
2. Development and use of such devices could be slow and expensive 
because of the cost of software development and regulatory compli-
ance. 
3. Microcomputers could transfer some of the workload of physicians 
in their offices to allied health personnel. Pulmonary function 
testing is an example. 
4. Use of the computer for the auditing of simple routine decisions, 
assisting in selected complex decisions, increasing access to medical 
data, and more rapidly communicating data were all felt to be major 
contributions. 
5. Microcomputers wi II find increasing use in diagnostic and therapeutic 
instruments. 
6. The need for standards development, quicker transfer of the technol-
ogy into practice, and the concern about regulatory compliance 
were emphasized. 
The terms "computer" and 11 microprocessor" are sometimes very confusing. 
From a programming standpoint, they are identical. That is, a person 
writing a program in Fortran, for instance, would proceed about the 
same whether the execution takes place on one commercial microprocessor 
or another. The differences are in the hardware. Microprocessors 
are usually smaller and slower. They are also considerably cheaper 
which lends them ,well to instruments that provide data which require 
·calculation to yield the desired results. Although -a -ty.pi.cal _processor 
chip may be purchased for $10, it may require $50,000 worth of program 
development, equipment, --and mc;n-year...s of time to write and debug 
the program. On a typical microprocessor system that rriighChave 
16K of memory, 8 parallel input/output ports, and all the necessary 
support chips, the hardware design time might be on the order of 
1 week. The program to analyze an FEV curve with this system 
wi II take 1 man-year to develop. Although micr.oproc~ssors have 
.advanced to a point almost beyond belief in small size and low cost, 
little has been done to accelerate the software development process 




People and Technologic Advances 
Technologic developments will not likely replace people in patient care. 
The spectre of an unattended patient controlled and monitored by machines 
in closed loop array Is not attractive . Technologic advances wi II, however, 
contlnut; to allow people caring for patients to operate at a level which 
would not be attainable if they were unassisted by machines. One has 
only to consider the Impact of blood gas analysis plus balloon tipped, flc·w 
directed pulmonary artery catheters upon the management of respiratory 
failure (failure of cellular respiration, tissue hypoxia). Whereas a 
short time ago, we were limited to nonquantitative clinical assessments, 
and subsequently could use arterial oxygenation (Pa0 2 ) only as a guide, 
we now can assess overall function of heart, lungs, and blood and 
the efficiency of heart and lungs relative to metabolic demand - (mixed 
venous P02 , arteriovenous 0 2 content difference, and right to left 
shunt fracflon). The patient ~re work load has not been reduced, 
but rather Increased, per patient, but the medical deliberations occur 
on a much different and more sophisticated level. Questions now rou-
tinely addressed in some centers could not even be formulated 25 years 
ago. Future technical advances wi II likely provide better assessments 
of the state of regional tissue (cellular) oxygenation. Admittedly, 
the ultimate impact of these new technologies upon mortality and its 
Impact upon the medical and general' communities is not yet known. 
NEEDS AND RECOMMENDATIONS 
• :0. .- --"! • ·~ • 
Standard techniques for data collection and equipment which 
meet minimum standards need to be established so that data 
can be exchanged between Institutions and centers. 
II 
Data bases should be established for: 
Pulmonary function testing to allow validation and testing 
of various instruments and software algorithms (for 
example a library of representative .FVC cur-ves). 
Reference (normal) values for pulmonary function tests. 
Assessing new techniques for quantitating pulmonary dys-
function and disability. 
Following the 11natural 11 course of pulmonary function in 
normal subjects and 1hose exposed to adverse environmental 
conditions . 
Monitoring and treating the critically ill patient so that 
treatment algorithms could be validated and implemented 
in computer assisted form. 
Development and testing of better diagnostic and treatment 




TECHNOLOGY NEEDS OF INTENSIVE CARE AND ANESTHESIOLOGY 
INTRODUCTION 
The care of patients undergoing surgery and Immediately following 
in the intensive care unit is one of the most demanding areas of medicine. 
Because there can be multiple organ failures and patients are so unstable, 
minute to minute measurerr.ents are often required which can quickly 
result in an overload of Information for physicians and, in some cases, 
result in less than optimum care. Therefore, the ICU/surglcal suite 
is an area where measurement, support, and computer technology may 
have the largest impact. 
The complexity of the clinical care of ICU patients and the resulting 
intense pressure on personnel have led many institutions to acquire 
ICU computer systems in attempts to Improve patient care and relieve 
some of the pressure on attending personnel. For these systems to 
serve their purpose requires three parallel developments: 1) the develop-
ment of new sensors; 2) the development of new testing procedures 
suitable for the ICU; and 3) the interpretation of these procedures 
to provide diagnostic and therapeutic information . As more and more 
sophisticated technology is introduced into the ICU setting, the National 
Institutes of Health (NIH) clearly must assume an important role in 
evaluating that technology before its use becomes widespread. A funda-
mental problem for all of the automated testing techniques is that their 
development, and the advocacy of their use, continues without complete 
testing, let alone: proof of their role In improving patient care. 
STATE OF KNOWLEDGE AND TECHNOLOGY 
Ventilation During Clinical Anesthesia 
The automatic measuring or monitoring of ventilation and assurance 
of its adequacy is a very difficult and unsolved problem in anesthesiology. 
However, since a large proportion of anesthetic mishaps In healthy 
patients (American Society of Anesthesiologists (ASA) .physical status 
1] is due to airway and/or ventilation problems, this is an important 
_area of concer-n. The concern here -i-s with monitoring lhe anesthesia 
machine circuit, -and which does not require devices attached to the 
patient (e.g., skin P0 2 electrodes). The most practical automatic <monitor-s 1"'-ely l()n 'Sensing pressure within the -tub1ng of the anesthesia 
machine. The majority merely sound an alarm If a period of time elapses 
without the pressure -exceeding a user selected threshold. A few ·have 
additional alarms -triggered by: 1) subatmospheric pressure; 2) pressure 
exceeding a preset threshold; or 3) absence of pressure oscillations, 
or pressur-e continuously above a preset threshold. 
Although these lattet· criteria improve the safety, the large variety 
of anesthetic circuits, the many different clinical situations in which 
they are used, -and the fact that all such methods de:tect pressure rather 
than ventilation Itself, point to the need for additional instrumentation, 
as Illustrated by the following: 
1. The monitor should function during spontaneous as well as during 
mechanical ventilation. During spontaneous ventilation, there is 
little pressure fluctuation In the anesthetic circuit. Flow and/or 
expired gas concentration (C02) monitoring is probably needed. 
2. The monitor should sound an alarm If the artificial airway (e.g., 
the endotracheal tube) Is not positioned correctly. With placement 
In the esophagus, pressures and flows may appear reasonably norma I, 
and sophisticated processing of such data and/or gas composition 
measurement may be needed. 
3. The monitor should function in the presence of severe lung dise~se. 
In such situations, pressures, flows, and expired gas concentrations 
may be quite different from normal, despite "optimal 11 ventilation. 
4. The monitor should function with a variety of anesthetic circuits 
or new anesthetic circuits should be devised which facili~te effective 
monitoring. If the latter course Is chosen, the other requirements 
of anesthetic circuits should be considered. The wide variety 
of anesthetic circuits include: 
Nonrebreathlng systems, and systems In which there Is CO 
absorption with total or partial rebreathing of expired g3ses. 
Systems with a wide variety of valves at many different positions 
as well as valveless systems. 
In some systems there is continuous flow past the endotracheal 
tube connection; in others, there is only flow on the inspiratory 
side during inspiration and on the expiratory side during 
expiration. 
5. Special considerations apply to small infants. For example, the 
tidal volume is so small that even in the absence of any ventilation 
due to obstruction of the airway, circuit flows and pressures during 
mechanical ventilation may appear normal. The compliance of 
the anesthesia circuit may be an order of magnitude greater than 
that of the infant. Monitoring expired gas concentration in the 
presence of very small tidal volumes also has severe limitations. 
Resolution ,of these problems and the development of new Instrumentation 
will require work along several -lines. These inClude: 
Determination of the various -ways in -which ventilation .can J.aH 
during anesthesia. Some Information can be obtained from 
empl't'"ftai :clinical surveys., but n.fffitult1es ,fn <Obtaining .accurate 
reporting wUJ make necessary the use of failure analysis and 
modeling. 
Determination of the ways various parameters (e.g., pressur es) 
change during failures. 
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Development of Instrumentation, including sensors for flow 
and gas concentration, which are practical for routine use 
during clinical anesthesia, along with development and testing 




Most ICU's utilize devices that fall into various categories, including 
ECC rhythm or arterial waveform monitoring (usually heart rate only, 
but occasionally rhythm information is also displayed), ventilatory support, 
and blood pressure monitoring. Devices currently available have a 
multiplicity of alarms with no standardization with respect to sound 
pitch, tonal quality, duration, or intensity. A standard recognizable 
audio code for specific categories of failure (blood pressure, rhythm, 
respirator disconnection, lew tidal volume, etc.) is highly desirable. 
Synthesized voice alarms should alsc be investigated. 
Usefulness of End-Tidal co2 as an Alarm 
End-tidal C~2 is being advocated as a generally useful method of monitoring patients in t11e ICU and operating room. Current evidence suggests 
that measurement of end-tidal C02 in the ICU has only limited usefulness. However, it may be an ideal parat:1eter to monitor in the operating 
room to prevent anesthetic accidents. To date, most monitoring of 
cardiorespiratory function hus focused on seriously to critically ill 
patients, i.e., those whose potential for recovery is limited (8, 13, 15). 
The young patient with a normal cardiopuln:onary system requiring 
elective cr simple emergent operative procedures has been neglected . 
As a result, fatal anesthetic accidents occur due to failure to provide 
adequate ventilation. A system is needed that assures, either directly 
or indirectly, that adequate ventilation is being provided at all times 
to support aerobic rr.etabolism. 
.• 
It has been suggested that a single mass spectrometer can be used 
to monitor a large nurr.ber of patients simultaneously by "time sharing" 
the device. fl.~onitoring of airway concentrations of C0 2 for cyclic variation 
of PC02, while at the same time monitoring inspired oxygen (F1o ) , 
could assist in assuring adequate patient ventilation. The operaflng 
room environment ..lends .itself to end-tidal ,co2 monitoring since :a-rt patients have some type of airway attachment. The anesthetic agents 
now in use also make most patients entirely dependent on ven~iJ~tory 
-support. 
T:o fundJon safety as mon-itors ()f ventifatton --and to prevent apnea of 
more than 60 seconds, the expired breath must be measured for a full 
respiratory cycle every 60 seconds. With conventional mass spectrometer 
time sharing systems, it is not possible to safely monitor more than 
4 patients at one tirr.e. However, recent modifications to the sampling 
systems -may allow gas ·"storage" in the tubing to reduce dwell time 
and increase sampling rates (14). 
···: .. ·~ ·.-: . .... . · .. :··-~ - '.~.-· - -
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These are mm1mum requirements for the use of end-tidal C02 to monitor the presence of active ventilation. Monitoring systems whicti sound 
an alarm for lack of C02 excretion or safe inspired 0 2 levels should be simple and easy to maintain and operate. If mass spectrometers 
are used, anesthetic gases as well as 0 and CO could be monitored. 
However I the primary goal must be to Jonitor al1 patients for the presence 
of cyclic changes in expired C0 2 , and not to develop a complex, expensive 
system that cannot be used univ~rsally. 
The national investment to develop facile, effective instruments for 
this type of patient protection is of critical importance. Despite the 
clear need for a form of monitoring to assure that anesthetized patients 
are being adequately ventilated, few such systems are in use in the 
United States - clear evidence that technologic development is needed. 
The installation in the ICU of mass spectrometer systems to monitor 
end-tidal CO is occurring at an accelerating rate. Yet, there have 
been few stu~ies of the reliability of the equipment, or the usefulness 
of the measurements in this environment. Spending large amounts 
of money to purchase such systems is not justified until their efficacy 
has been demonstrated. As noted above, conventional mass spectrometer 
systems cannot be used to monitor ventilation and prevent apnea for 
more than 4 patients, since the time before return to each patient 
is too long for safe monitoring. Most systems installed in ICU's attempt 
to serve more than 4 patients, or are used only on selected patients 
in the ICU. They are not used as apnea monitors. 
In most ICU systems, measurement of end-tidal C02 (PetC0 2} is used to predict PaC0_2 by averaging the expired C0 2 peak value from conse-
cutive expired Dreaths. The accuracy of the e-stimation depends on: 
1) a consistent breathing pattern with breaths of equal volume and 
uniform rate; and 2} no significant (A-a) C02 gradient. If the (A-a) C02 gradient is measured, then PetC0 2 could be used as a predictor of PaC02 if the (A-a} C02 remained constant. 
With unsteady state res pi ration, the measurement of peak end-Udal 
CO and averaging the measured values are not predictive of PaCO . 
With increasing use of intermittent mandatory ventilation (IMV), wi~ 
an unsteady ventilatory rate and tidal volume, PetCO is not likely 
to be useful. In addition, respiratory failure is chafacterized by a 
changing (A-a}C02 gradient, and no studies are yet available to show how one -can :interpret PetCO under these conditions. Before further 
-expenditur..es -:9re made on thfs type of instrument, definitive studies 
of the usefulness of the equipment must be made. -For -example, meas.ure-
ments .to weight the individual PetC~2 values before averaging of end-tidal co2 may be more useful if com"t5ined 'With measur-ements <Of .tidal 
volume. 
Ill 
Measurement of Cardiac Output 
Acute r:spi ~atory insufficiency can result in pulmonary edema with 
a resultmg Intrapulmonary shunt. The survival of these patients Is 





The amount of oxygen delivered to the tissues is the product of cardiac 
output and arterial oxygen content. Decreases In cardiac output directly 
lower oxygen delivery and indirectly lower pulmonary capillary 0 2 
content (CaO ) . With a significant intrapulmonary shunt, the level _ 
of Ca02 is cfltically dependent on mixed venous oxygen content (CvOJ). Wtten cardiac output falls, oxygen extraction from blood increases an 
Cvo2 falls, and with no change in shunt fraction, CaO falls. C (a-
v)02 is used as a measure of the ratio of cardiac outpbt to metabolic 
rate. However, dl rect measurement of cardiac output is of critical 
importance in assessing the efficacy of therapeutic manipulations In 
patients with Adult Respiratory Distress Syndrome CARDS). The importance 
of such measurements has been clearly documented in adults. Without 
technology for measurement of cardiac output in neonates and infants, 
this same knowledge cannot be used. Since placing catheters in the 
pulmonary arteries of neonates has resulted in thrombosis and other 
serious complications, the adult technology (cardiac output by thermal 
dilution) is not usable. For this reason, infants must be treated without 
knowledge of cardiac output. Development of a method of measuring 
cardiac output In neonates and small children could markedly enhance 
treatment of respiratory insufficiency in the neonatal period. 
There are special problems with measuring cardiac output which might 
also make it less important in children than adults: 1) the lower incidence 
of myocardial disease and heart failure (in the absence of congenital 
heart defects), and 2) the difficulty of interpreting the output in the 
presence of shunts. 
IV 
Oxygen Toxicity 
The primary and most commonly used form of treatment for patients 
with acute and chronic respiratory disease is administration of increased 
concentrations of oxygen. The dependence of life on oxygen is paradoxical 
since life Is also threatened by oxygen's toxicity (1, 3). This paradox 
has led to great interest in oxygen toxicity, and present s.tudies indicate 
that the concentration of oxygen which can be toxic wi II not be absolutely 
definable. 
Under certain circumstances, even a PO of 150 mm Hg can_be injurious. 
This problem is most apparent in studie~ of superoxides (0 2). Superoxides 
are produced in large quantities by granulocytes and proviae one .of 
the important factors in phagocytosis -(9). At the same time, they cause 
damage to biological structures such as nucleic acids, lipids, and proteins. 
In addition to the role of superoxides 4 lhe SH -enzymes -in ce11s are 
~xtremely sensitive to oxygen. Superoxides can be lethal to cells if 
the concentration is too hi,gh to be contr:oUed by intracellular enzy~ 
<Or if they -are generated ;n 'the extracellular space. Superoxide dismutase 
is a major enzyme providing protection from superoxides, and under 
some circumstances, exposure to high concentrations of oxygen can 
increase the concentration of this enzyme and, thereby, increase the 
concentration of oxygen that can be tolerated. For example, rats exposed 
to F1o2 of 0:85 adapt s~ that F 0 .o! 1. 0 is tolerated, while an F1o2 
of 1 .,0 IS uniformly -fatal to uncbn~1t10ned rats. The adapted rats have 
an increased level of superoxide dismutase in their lungs. 
·- ·!!::r"-- ..- :---;-· - - ~----- ~ ---.r-h~---~-
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Oxygen toxicity, as are all toxicities, is relative and varies between 
species and individuals within species as well as in an individual. 
A number of quetions need answering regarding the potential dangers 
versus benefits of the use of augmented concentrations of inspired oxygen. 
Does an elevated F 0 1) increase the production of superoxides by 
granulocytes and, ft \o, does this increase injury to normal structures 
of the lung? 2) make the lung more susceptible to injury by superoxides 
when infection occurs and defense mechanisms are activated? and 3) to 
what extent can the sick lung adapt to protect itself from the toxic 
effects of oxygen? (For example, are reports of patients surviving 
after long periods (days to weeks) of F10 2 near 1. 0 examples of patients 
who have adapted slowly by increasing errzymes to inactive superoxides 
or other destructive effects of hyperoxygenation?) 
It can be concluded, even without answers to these and many other 
questions regarding mechanisms by which, and levels at which, oxygen 
is toxic, that elevated levels of F10 are potentially dangerous. If this tenet is accepted, then an imm~diate aim of technology should be 
to develop techniques that limit to the maximum extent possible, patient 
exposure to elevated concentrations of oxygen. 
v 
Role of Airway Pressure and Flow Monitoring 
Technology is presently avai !able tor facile measurement of tidal flow and 
airway pressures in intubated patients (7, 10-12). The cost of devices 
to monitor flow and pressure is comparable to the cost of monitoring the 
ECG and two vascular pressures. Measurement of flow with presently 
available devices requires attention to the flow transducer to prevent fouling 
with secretions or condensed vapor. Flow transducers that are relatively 
simple to maintain have an absolute accuracy that is not much better than 
5 percent and is typically nearer 10 percent. However, these transducers 
can monitor changes in flow with greater accuracy. 
Measurements of airway flow and pressure are of little value if unprocessed, 
so useful devices must include some form of data processing. The most 
versatile and economic method of processing will be on-line digital micro-
processors. Current pattern recognition, computation, and display 
algorithms need further development before standards are established. 
Monitor Capability 
At present, it would appear that the capability of the flow- pressure 
monitor should ·include: 
· Stand-alone instr,uments .that could be used for any intubated pati ent 
regardless of whether the patient is breathing ~pontaneously :or 
attached to any of a number of different types of ventilators . 
. The capability to measure, with an accuracy of ±S percent, Inspired 
and expired tidal volume, ventilatory rate, and minute ventilation . 
The ability of separating spontaneous from ventilator breaths when 
IMV is in use and, thus, measure spontaneous rate and tidal volume, 
and venti later rate and volume, and thereby, calculate the contributions 
of each type of breathing to minute ventilation. 
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· The measurement of peak, mean, end-expiratory and end-inspiratory 
airway pressures, and the average of these over a 1-minute time 
interval. 
· The use of pressure and flow measurements to calculate compliance, 
resistance, and work, · preferably with an algorithm that predicts 
reliability of calculations. This type of data acquisition and computation 
wi II require special training of medical and nursing personnel. 
· The capability of measuring transpulmonary rather than airway 
pressure if an intrathoracic pressure is available. The pressure 
manometer should be a differential manometer. This wi II allow 
calculation algorithms to measure compliance, resistance, and work, 
regardless of the mode of venti latlon. 
Monitor Evaluation 
Monitors with these capabilities would permit design of clinical studies 
to evaluate how useful this information would be in the management 
of respiratory therapy. Major questions that need to be answered are: 
Does the ratio of spontaneous to ventilator tidal volume, respiratory 
rate, and minute ventilation predict effect of changes in level of 
venti later support needed? 
· Does knowledge from flow-pressure monitoring reduce the need 
for blood gas determinations, barotrauma, ventilator accidents, 
and duration of ventilator support? 
· Is a flow and pressure sensor system an effective monitor for pre-
vention of anesthetic apnea accidents? How effective is it compared 
to sensors with gas concentration measurement capabi lilies? 
• Does knowledge of lung mechanics permit more precise control 
of the level of increased end-expiratory pressure, and ventilator 
tidal volume? Can it reduce barotrauma or depression of cardiac 
output? 
Is automated interpretation essential for effective use of the data? 
This list must be considered a partial list of pertinent questions. 
The new technology is not the capability to measure flow and pressure, 
.but .the -.on--line processing -of information from these sensors. The 
usefulness depends on the further technical and clinical applications 
of the potential of these <:apabi lities. These simple measurements may 
prove to be some of the most useful signals for controlling ventilator · 
therapy and preventing its complications. The studies wi II require 
GOOrdi.nated ~valua·tion t:if ventilalion-perlusiun -distribution, cardiac 
output, and PaO 2 . 
Finally, studies of Petco2 when combined with simultaneous tidal volume 




Invasive and Noninvasive Blood Gas Measurements 
There is no doubt that noninvasive, transcutaneous PO electrodes 
are practical for use on infants, with several good instruments on the 
market. In the older age group (above 6 months), the circulation 
to the skin varies greatly with the clinical state so that oxygen may 
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be consumed at such a high rate that transcutaneous PO may be much 
lower than arterial P0 2 • The sensors need to be effectite when perfusion Is poor, or provide a reliable warning that their signal is poor. Present 
sensors, including oxlmeters, are uncomfortable, unreliable, and expensive. 
Potential solutions to this problem include: 
Increase local skin perfusion. 
Unfortunately, this may not be 
risking an unacceptable burn. 
using pharmacologic methods. 
This is currently done with heat. 
adequate in the older infant without 
It may be worthwhile to investigate 
· Decrease skin 0 2 consumption. Again, pharmacologic methods 
should be tried . Considerable basic research should be done, 
however, before clinical trials are conducted. 
Invasive sensors for measuring arterial or mixed venous P02 , PC0 2 , 
and pH would be useful in certain critically ill patients. Tneir de~elopment 
should be encouraged, but cost and reliability must be scrutinized. 
VII 
Measurement of Vital Capabity 
T.he measurement of vital capacity (VC) and its use in clinical decision 
making In critical care is not widespread, in spite of the fundamental 
role of VC in monitoring the state of many cardiopulmonary disorders. 
Decisions concerning the application or withdrawal of ventilatory assist-
ance, the progress of pulmonary congestion due to left ventricular 
failure, and the progress of neuromuscular disorders affecting ventilation 
are frequently made more easily and rationally in light of a well-determined 
measurement of VC. The progress of patients with airflow obstruction 
(bronchitis, emphysema, asthma, etc.) is frequently only rationally 
assessed by measurement of the FEV 1 (or a substitute measurement 
of flow). Application has clearly Jagged behind the availabi'lity of 
devices. 
VIII 
Detection of Pneumothorax 
A large tension pneumothorax is life threatening and requires Immediate 
spedfii: 'therapy~ t.Jnfor.tunately"T the .therapy (aspiration of pleural 
air by needle or chest tube) is Itself a potentially dangerous pr~·cedure 
and may itself cause a pneumothorax. X-ray diagnosis is potentially 
of extreme benefit and presents .an acceptably low risk. Unfortunately, 
it is, In many practical clinical situations, far too ·time consuming. 
There is urgent need for a simple noninvasive and rapid procedure 
for determining the presence of pneumothorax. It Is essential that 
the method define the side on which the pneumothorax is located. 
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ICU DATA TYPES AND FREQUENCY OF COLLECTION 
To list data important to collect and frequency of required collection for 
intensive care wi II inevitably reflect the prejudice of authors and wi II be 
probably obsolete as soon as it is written. If these limitations are accepted, 
the following is a list of data that can be acquired in mid-1980 and which has 
proved useful for control of treatment in the intensive care environment (2,4-6). 
Acquired Data 
1. Arterial PaC0 2 , pH, Pa0 2 , Hgb or Hct, 
FI02 
In infants, trans-
cutaneous PaO 2 , PaCO 2 
Derived Variables 




Depends on patient 
status, rarely more 
than qlh 
Continuous 
If reliable, comfortable, and reasonably priced continuous indwelling 
surface monitors of PaC02 , pH, or Pa02 for adults become available, 
should be substituted for blood sampling. R 
or 
they 
2. Mixed venous oxygen 
content ( CvO 2) 
with 1), A-V DO , 
with vo2, cardiat 
output 
Q /Q > 0. 15, 
C,Afl or PEEP > 10, 
with changes in treat-
ment, cardiac output, 
or clinical state 
If reliable catheter tip instrument becomes available to measure Cv02, it 
should provide a near continuous monitor. 
3. ECG 
4. Systemic arterial 
pressure 
'5. Pulmonary artery and 
wedge pressure from 




Heart rate, frequency 





mean and wedge pres-
sure, preferably 
coordinated with 
phase and type -of 




In patients on tPAP > 10 
and those with cardio-
vascular instability. 
Pulmonary artery pressure 
continuous. Wedge pres-
sure q30min to 1h 
• 
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ICU DATA TYPES AND FREQUENCY OF COLLECTION (continued) 
Acquired Data 
6. Cardiac Output 
7. Airway flow and 
pressure 




9. Fluid electrolyte, 
blood products in-
take, output 
10. Serum Na, K, Cl, C0 2 
Derived Variables 
Cardiac Index, pul-
monary and systemic 
vascular resistance, 
left and right stroke 
work index. If Ca02 
and c.v02 available, then vo2 
Spontaneous and ven-
tilator tidal volume, 
rate, minute ventila-
tion; mean, peak and 
end-expiratory pres-
sure (compliance, 
resistance, and work 
if proven reliable) 
Tidal volume, vital 
capability (VC) , forced 
vital capacity (FVC} , 
FEV , inspiratory and expi~atory reserve volume 
Fluid, electrolyte, 
blood product net 
gains, losses. Hourly, 
daily, and cummulative 
Frequency 
In patients on CPAP 
or PEEP > 10 and/or 
those patients with 
cardiovascular in-
stability, q1h or 
when therapy changed 
q60-120min for testing. 
Continuous if used as 
apnea monitor. (For 
latter, expiratory flow 
and peak inspiratory 
pressure adequate.) 
q12-24h or with change 
in ventilatory treatment 
or status 
q1-3h, dependent on 
state of patient 
K+ wh~n critical q1h. 
Otherwise q8h if good 
balance determinations 
available 
If indwelling sensors that are comfortable, reasonable in cost, and accurate 
·are ·available, this .information could be available constan!!Y. This .facili-ty 
is of questionable value. 
11 ~ Urine Na., K, Cl 
12. Lung water 
Use for electrolyte 
balance calculations 




NEEDS AND RECOMMENDATIONS 
Methods should be developed and applied to evaluate technol -
ogies used in the care of critically ill patients of all ages. 
II 
Studies should be undertaken to delineate the efficacy of 
high frequency ventilation (HFV) and those conditions in which 
its use is recommended. 
Ill 
Equipment utilization at the bedside should be reviewed to 
define that instrumentation and support equipment essential 
to optimize patient care. 
IV 
Major emphasis should be placed on the development of methods 
which will detect and sound an alarm following ventilator and 
anesthesia machine disconnects. 
v 
Further development of noninvasive methods for measuring P02, PC02 and pH in adults, children, and patients with poor perfusion is needed. 
VI 
Development of noninvasive methods for measuring all important 
physiological parameters, such as pulmonary blood pressure, 
arterial pressure, P02 ~ PC02 , etc. would min1mize risk to the patient and maximize 't1ata access for decision making. 
VII 
"Further studies of the mechanisms of oxygen toxicity and its 
prevention should be encouraged. 
VIII 
Studies should be conducted to assess the benefit of airway 
flow and pressure measurements, and to determine in which 
patients this type of monitoring is warranted. 
IX 
Improve flow measurement technology so flows can be 1) accurately 
measured in the ICU patient environment where varying flows, 
temperatures, and plugging are major problems, and 2) measured 
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COMPUTER ANALYSIS OF MEDICAL IMAGES 
INTRODUCTION 
Recent advances in computer technology, with a corresponding reduction 
in computer costs, have made the application of image processing and 
enhancement techniques to medical problems more feasible. In addition, 
data are now more frequently in digital form such as data from computed 
tomography and digital radiograph systems. Operations which were 
once too time consuming to be practical are now possible through 
whole image operations with multiprocessor systems (11, 13). Faster 
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image processing will also significantly improve interactive image analysis. 
Digital processing methods may also result in lower radiation doses 
(15). 
Epidemiological studies and medical surveillance programs frequently 
use chest radiographs as part of their medical protocol. With these 
usages, large numbers of mostly norma I radiographs must be interpreted, 
and computerized analysis Is particularly attractive because of the large 
number of interpretations which must be rendered, the relatively narrow 
range of diseases encountered, and the significantly larger interobserver 
reading variability. In addition, a computerized system may provide 
an increase in the sensitivity for the detection of low level radiographic 
changes which can occur with some occupational exposures. 
In applying computerized analysis of radiographs to epidemiological 
and survei fiance programs, accurate validation is most important. 
With proper validation, it is conceivable that a computerized system 
could outperform the human observer in a limited number of radiographic 
disease manifestations. 
STATE OF KNOWLEDGE AND TECHNOLOGY 
Image Resolution 
The first consideration in computerized analysis of medical images is 
the spatial, temporal, and density resolutions needed. In general, 
hl_gher resolutions require considerably more processing time and increase 
the cost of the system. Image acquisition technofogy is now reaching 
the level at which some comprehensive analysis , of resolutuion requirements 
for CT scans are needed. For example, the need of increasing spatial 
resolutions beyond 0.4 mm should be reviewed. 
'II 
Preprocessing Algorithms 
After -a medical image has been acquired, it must usually be preprocessed 
or enhanced. The preprocessing algorithm used is often very dependent 
on the origin of the image, i.e., a digitized radiograph or comput~d 
tomography system. Preprocessing can range from applying a reconstruction 
technique to a CT scan, to the use of spatial filtering and edge enhance-
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ment to accentuate certain regions of the image for display. Image 
preprocessing techniques have also been used for normalization of 
a radiographic image to compensate for variations in film quality (5). 
While there is a need for more and better preprocessing algorithms, 
they must be considered within the context of the origin of the image. 
Ill 
Image Segmentation 
One advantage of computerized analysis of medical Images Is the vast 
amount of quantitative Information which Is available In the digital 
Image. However, for this information to be extracted, the Image must 
first be segmented Into regions of Interest. Segmentation may be per-
formed Interactively or be completely automated. Once the region of 
pathology has been Isolated, a number of quantitative measurements 
such as area, density histograms, and texture measurements can be 
computed. Thus, with computer assisted segmentation, the tedium of 
manual delineation of areas of interest is reduced and quantitative measure-
ments are often more reproducible. 
Quantitative information from CT systems has been used in the diagnosis 
of pulmonary nodules (1), demonstrating one future use of either automated 
or Interactive Image segmentation. Image segmentation algorithms have 
been used on skull CT scans (3, 7) and similar techniques could be 
applied to CT scans of the lung. One method of stimulating the develop-
ment of segmentation algorithms would be to establish a computer image 
data base of lung anatomic information. Then, various segmention 
algorithms could be developed, compared, and evaluated for possible 
Inclusion in CT system software libraries. 
Numerous applications of modern image processing techniques have 
been made to digitized chest radiographs (9). Much effort has been 
directed towards development of algorithms to outline the lungs and 
heart and extract measurements for automated determinatjon of heart 
disease (6). Other efforts have examined the lung field fer. tumors 
(2) and detection of infiltrates (14) with partt'cular emphasis on pneumo-
conioses (10). Work has also been done on locating the ribs (4) prior 
to any quantitative measurements. Although much work has been conducted 
on image analysis of chest radiographs, more wor k Is needed to validate 
these methods on a large number of radiQgraphs. Automated analysis 
of radiographs will be ·most useful in screening, epidemiological, and 
surveillance programs where a wide variation in film quality and disease 
patterns exist. As with CT data, the establishment of a well validated 
and representative computer image data base would be an important 
first step tow.ar.ds .evaluating thes€ -~igorlthtns. ·'Such a data base would 
serve as a bridge between physicians and computer specialists. 
lV 
Display Technology 
One of the limiting factors in the Interpretation of an image is the mismatch 
between the observer and the image display system. Through the 
use of image processing and display techniques (such as pseudo color 
display) more efficient display of radiographic and CT images is possible. 
1-.. 
More work Is needed to optimize Image display for decision making. 




Feature extraction Is the reduction of the number of parameters in the 
original pattern space to a smaller subset of the most relevant feat~res 
with respect to classifying an observation. For example, feature extrac-
tion techniques have been used In the analysis of chest radiographs 
to select the best measurements from the cardiac silhouette to classify 
heart disease (6), and to determine which texture measurements are 
the most useful In the diagnosis of interstitial fibrosis. 
Feature extraction techniques have also been applied to respiratory 
data. For example, feature extraction has been applied to an analysis 
of flow volume curves to improve their sensitivity and provide an under-
standing of the Information content of the flow volume curve (11). 
Feature extraction and pattern recognition techniques can be applied 
to a variety of medical decision processes and are particularly useful 
when parameters are highly correlated or redundant. More effort 
is needed to apply these techniques to respiratory data, not only to 
develop decision making algorithms, but also to provide a basic under-
standing of the data. 
NEEDS AND RECOMMENDATIONS 
Studies specially designed to validate computerized analysis systems 
should be conducted. 
II 
The development of more efficient image display methods, especially 




The application of featur.e extraction al_gorithms to assist in 
medical decision making should be pursued . 
1V 
Establish evaluation criteria to determine the incremental 





The establishment of a representative image data base to allow 
physicians and computer scientists to develop, test, and validate 
human and computer image extraction and analysis techniques 
should be fostered. 
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The National Heart, Lung, and Blood Institute is to be commended on 
its previous efforts in the standardization of data collection for epidemio-
logical purposes. Standardization is also important for the routine 
clinical respiratory tests which are used at most medical facilities. 
The best approach to standardization is through the support of professional 
and technical societies which are interested in setting or recommending 
standards. An example is the recent American Thoracic Society {ATS) 
effort on spirometry standardization. Standardization for blood gas 
analysis, single breath diffusion, and exercise testing should be given 
high priority. 
The establishment of equipment testing centers is not necessary if 
voluntary standards have been developed. Standards alone are often 
sufficient to encourage manufacturers to improve and evaluate their 
instruments. Unti I the medical community can agree on performance 
requirements, manufacturers wi II continue to guess at what is needed . 
Once performance requirements have been defined, manufacturers have 
generally been willing to conform to the standards and even test their 
devices to ensure that their specifications are accurate . 
I 
STATE OF KNOWLEDGE AND TECHNOLOGY 
The Intermountain Thoracic Society, the California Thoracic Society, 
NHLBI 1s Division of Lung Diseases, and the American Thoracic Society 
have all made major strides in establishing standards for procedures 
and data interpretation (1-4). The development of standards for spirometry, 
which Included instrumentation requirements, test procedure requirements, 
and data selection requirements, has had a positive effect on manufacturers 
and clinical users. These standards have developed meth.ods so we 
can now generate and share interchangeable data. Standards for pulmonary 
medicine should be developed carefully, so as not to stifle Innovation, 
nor slow the development of better, and more sensitive and specific, 
test methodologies . We should not, however, wait 130 years, as has 
been the case with spirometry, to develop meaningful and .practical 
standards. 
-It Is extJ~emely ·1mportant 'to -have longitudinal and -Intergroup comparisons 
of epidemiological data. These would aid in the early detection of 
hmg disease., provide c Unh:af ·comparisons r-elating ·to .Jndividua·l diseases 
and the effects of drugs and therapy, and allow for fair and equal 
evaluation for disability. The current Snowbird (2) and epidemiological 
{1) standards that have been published are steps in the right direction; 
however, they might be made more readily avalfab1e, perhaps, in a 
condensed form. These standards should probably be attached to all 
relevant research applications . There does not seem to be a great 
deal of concern for following these standards among the medical profession, 
and were it not for the leading manufacturers fighting It out through 
their advertising, these standards might never have been implemented. 
Industry has mixed feelings about the standards that have been published. 
.. .;. .. 
Obviously, if one firm meets all of the requirements with its equipment, 
it wi II support enforcement while those that fail question the validity 
of the standard. The larger companies can accept the expensive, and 
often hard to obtain, equipment necessary for accurate testing, while 
the smaller companies find It a financial burden. Most companies in 
the business of manufacturing Instrumentation for pulmonary function 
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have sales under $10 million per year and are more concerned with 
product development and marketing than with engineering, basic research, 
and physiologic problems. Too much enforcement could result in driving 
smaller companies out of business with only 2 or 3 of the larger ones 
surviving. Perhaps, the answer is the establishment of centers for 
instrument testing. 
The other half of the problem Is that pulmonary laboratories presently 
are not certified and often neither is the operator. How does one cbt<.~r-mine 
If the machine was properly calibrated or the test performed correctly? 
Registration? Regulations? There is little hard evidence that certifi-
cation improves quality. 
Probleflls of communication are common to groups both within and outside 
of government.- The Federal agencies currently involved with health 
care suffer from a lack of coordinated action. The benefits of a coordinated 
government approach to health gu-e and technology development are 
obvious. However, the deleterious effects of unilateral, uncoordinated 
actions are often less obvious. Frequently, the policies of one govern-
ment agency, although fully in concert with its statutory authority, 
cause a ripple effect throughout the industry which manifest.c; itself 
in ways completely unconsidered. The formation of an intragovernment 
health coordination group, similar to the Interagency Regulatory Liaison 
Group (IRLG) composed of representatives from various government 
agencies involved in health care (e.g., FDA, NIH, NCHCT, HCFA, 
HRA) may alleviate some of these problems. The coordinating group 
would meet periodically to keep appraised of the issues of concern 
to each group and the policies being considered for implementation. 
In this manner, policies could be evaluated .for their effect, if any, 
on other groups before, rather than after, implementation. Unilatera I 
policy often leads to confusion within the government and industry 
with the potential for economic Joss. The problems of communication 
between groups outside of government are compounded by their diver-
·sity and distance. -The basic problem, simply stated, is how to encourage 
communication between those people with a problem (e.g., the physician)# 
_and those people who may have -a solution -(e~g., the engineer {)I"' industry). 
Stimulation of this type of communication may require the establishment 
of .some type .of J.nfor-maUon EK<:hange~ rA 1lOssfble <s-cenario might 'be 
the formation of a computerized data base, maintained by the Federal 
government, consisting of professional organizations and their areas 
of expertise. tn this manner, periodic reports of health issues could 
be made publicly available to these groups for dissemination to their 
members. The data base would be maintained, updated, and coordinated 
by the Federal government. In this manner, unresolved problems 
could be brought to the attention of the widest possible audience, with 




Protocol definition and standardization of measurement techniques In 
both the pulmonary laboratory and the Intensive care unit is highly 
desirable. Although standardization of splrometers and spirometric 
methodology, body plethysmography, and esophageal pressure measure,.. ; 
ments, have received much attention during the past 5 years and likely 
herald future major efforts towards standardization of many pulmonary 
laboratory techniques, major advances in critical care have occurred 
so rapidly that with the exception of electrical safety regulations, virtu-
ally no other effort towards standardization In the ICU has been made. 
The measurement of pulmonary artery wedge pressure (Pw), for example, 
is very difficult in many clinical settings, and Is associated with major 
and clinically significant errors, the frequency of which Is currently 
unknown. Techniques used for measuring Pw are quite variable from 
center to center. The techniques used for portable chest x-rays (1. e., 
exposure, focal spot to film distance, patient position, removal of monitoring 
leads, size of breath, etc.) are equally nonstandard with the result 
that portable chest x-ray quality varies from unacceptable to excellent. 
Specimens of blood for blood gas analysis, when hemoglobin concentration 
Is included (required for 0 2_ content calculation), must be associated 
with a known and fixed dilution factor (due to anticoagulant volume) 
and must be adequately mixed (not a trivial problem with modern blood 
specimens contained in syringes without air bubbles or foreign bodies 
such as glass beads, metal wires, etc.) before analysis. 
NEEDS AND RECOMMENDATIONS _.. 
The development of "flexible" standards for devices and methods 
which have reached maturity In the pulmonary area should be 
strongly encouraged. Examples are: 
Spirometry, including establishment of reference "normal" 
values 
Dilutional lung volume testing 
Pulmonary questionnaire 
Body plethysmography 
X-ray lung volume determination 
Criteria for interpretation of chest x-rays 
Blood gas analysis 
X-ray film .quality 
Measurement of pulmonary artery wedge pressures, especially 
in patients with pulmonary disease 
II 
Encourage utilization of currently developed standards by 
having all 9overnment agencies and professional organizations 
adhere to a single standard (this has been accomplished with 
spirometry) . 
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On October 31, 1979, President Carter announced a program to encourage 
Industrial Innovation emphasizing the Importance to the American economy 
of the development and commercialization of new products. The Improvement 
of health care was one of the primary directions for this program (1). 
The application of medical technology to health care represents the 
final step In a long series of events consisting of Inputs from both 
public and private sectors. At any stage In the developmental process, 
these Inputs can exert either a constructive or destructive Influence 
on technological progress. 
STATE OF KNOWLEDGE AND TECHNOLOGY 
An Important factor In the development of medical technology Is the 
role of the physician and the medical system. Physicians are keenly 
aware of those areas in medicine where new technica·l advances are 
needed or where developments are delayed. Physicians are continually 
presented with diagnostic and"or therapeutic challenges which must 
await the advent of new technological discoveries. The Interaction 
between these physicians and the engineering community represents 
a basic link in the innovation process (2). However, this link often 
develops haphazardly, and the problem becomes one of how to fortify 
this link between the medical and engineering communities to elicit 
the development of needed products. The coordinated efforts of government 
agencies such as the National Institutes of Health which are heavily 
involved in the research and development of medical technology through 
both intramural research and extramural funding, the National Center 
for Health Care Technology (NCHCT) which Is Involved ip the assessment 
of medical technology, the Food and Drug Administration (FDA) which 
evaluates the safety and effectiveness of new p"roducts, and the Health 
Care Finance Administration (HCFA} which provides reimbursement 
for medical expenses, can stimulate the development of needed technologies. 
Each of these agencies represents a part of the innovation process, 
and each may be constructive or destructive in that _process. 
The first part of the innovation process Is the Identification and funding 
-.:vf -areas :-where -research is -needed. The 1-Jationai ·institutes of-'Hea-ith 
currently has a mechanl sm for this purpose. Through tasl< forces, 
.areas ef medicine are identlfled where -addltiona1 clin1ca1 'lnformatlon 
would result in more effective treatment. Often, these areas are ones 
with little economic potential because of either the small market or 
the high cost of development relative to the potential return. There 
are two possible approaches to stimulating development In these areas. 
The first 1 s to increase government funding of research. The second 
is for the government to bear the entire cost of development, relying 
on the private sector only for the production and commercialization 
of the product. 
The passage of the Medical Device Amendments of 1976 gave the Food 
and Drug Administration the statutory authority to ensure the safety 
_. 
and efficacy of medical devices. These amendments provide regulatory 
safeguards to address the potentially devastating effects of unsafe or 
inefficacious medical devices. While regulatory control was designed 
to protect the consumer, it has the potential to injure the medical device 
industry by delaying the development and commercialization of new 
devices. This deleterious effect of regulation can, however, be minimized 
by the development of a priority system under which innovative products 
with exceptional benefit would undergo an expedited clearance. Under 
this system, the Bureau of Medical Devices (BMD) would Identify candidate 
devices from information submitted to the Bureau In response to regulatory 
requirements [e.g., investigational device exemption (IDE) applications; 
product development protocol (PDP)], from direct contact with device 
developers, from the professional literature, or from information provided 
by organizations currently funding device research and development 
(e.g., the National Institutes of Health). These candidate devices 
would then be evaluated according to a classification scheme. This 
scheme evaluates the devices on the basis of two factors; 1) the level 
of innovation over current technology, and 2) the diagnostic or therapeutic 
potential associated with the device. These two factors are then further 
subdivided, the truly new and unique device from the device without 
Innovation and the device with an exceptional medical/social benefit 
from those with little or no medical/social benefit. Devices ranked 
high on this classification scheme would be candidates for expedited 
FDA review. Devices selected for expedited review would be encouraged 
to utilize the PDP process, whi~ offers the greatest flexibility In expe-
diting premarket clearance. Under this process, the Bureau in concert 
with the manufacturer and the appropriate device advisory panel would 
develop and agree upon a protocol for testing the device. Continuous 
t·eview of the data generated during device testing would eliminate 
the serious delays caused by unproductive or Inappropriate testing. 
Any problems arising during the course· of testing can be immediately 
rectified without adding additional delays. An alternative approach 
to expediting the review of medical devices Includes the use of the 
IDE/PMA (premarket approval) process. However, this process is 
less flexible than the PDP process due to statutory constraints. Devices 
rated high on the classification scheme would r~ceive a high priority 
for Bureau review. If submitted early enough, deficiencies in the 
investigational protocol could be rectified In a manner similar to the 
PDP process. Furtherwore, regulatory discretion in approving a device 
could be applied to a device rated high on the classification scheme, 
·but which does .. not, ~as ·yet, ·-meet all ·the statutory requirements -for 
approval. Jn this manner, _the _device would be available to the public, 
contingent upon a subsequently successful completion of all statutory 
requirements. 
Another area of 'FDA authority, similar in some aspects to ·pop and 
PMA guidelines, is that of standards. Standardization can potentially 
encourage or discourage innovation. Rigid standards will undoubtedly 
deter technology development. The establishment of performance standards 
specifying only the required goal, rather than the means of achieving 
H, will stimulate the development of efficient, cost effective products. 
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The adoption of acceptable reference standards against which a manufacturer 
can check his product eliminates costly testing and decreases regulatory 
WM ., ... '; ·~ ·.' l • 
-
254 
review time. The benefit derived from the standards process can only 
be achieved if there is widespread acceptance of a particular standard, 
which necessitates the coordination and involvement of users, government, 
and industry. A standard responsive only to the interests of a single 
group wi II inhibit, rather than promote, development. 
The final aspect of the innovation process is the stimulus provided 
by government reimbursement agencies and other third-party payers. 
Certain areas of medicine (e.g., preventive medicine) exhibit little 
progress in the development and utilization of technology. The reason 
for this lack of progress may, in part, be due to the lack of third-
party payment. Practitioners may be reluctant to utilize new technology 
when the cost may have to be borne by the patients themselves, especially 
if it is not clearly demonstrated to be clinically superior. But where 
the expense is covered by soine form of health insurance, a demand 
for the technology can be generated, stimulating the market place to 
fill it. Reimbursement can be an effective tool for stimulating innovation, 
if it is appropriately managed and properly targeted. 
Each of the elements - reimbursement, funding, standardization, 
and regulation, affect the climate for innovation. While no singular 
element is sufficient to stimulate innovation, each can stifle it. A program 
to truly encourage technological development requires a coordinated 
effort by the agencies and individuals who are responsible for overseeing 
these areas. Users, developers, and regulators of medical technology 
should identify areas of high priority for development and expedite 
the development process. Government is not the sole determinant of 
the process of technological development, but requires input from consumers 
and industry to encourage innovation. Some of the elements of this 
concerted effort are already in place, but without the remaining elements, 
the results fall far short of the desired goal. 
Industrial Perspectives 
The usual course of research in industry might have the following 
scenario. Someone has a basic science idea, fol1ows it up with a research 
grant or support from a large company, and ends up with a basic 
science publication. This stimulates interest in applied science research 
leading to clinical research and a clinical publication. The end result 
is that information is generated to aid the _person in charge .of .patient 
care ·and tt ·may create a ·markel for a product. All this falls down 
in bioengineering. .First of ,aJJ, ·the ·basic science is usually further 
removed from -:the clini.ca! -setting -than ~s -the -case -wi-th drugs or chemistry. 
Secondly, publications of basic science or even applied science are 
unacceptabJe .to .medi.ca-1 journals where physicians could benefit, and 
,vhen rarely accepted, are either incomprehensible to possible users 
or too simplified as to be of any use. The need for cooperation between 
bioengineers and medica1 people participating in multidisciplinary research 
is crucial for the health car.e field to be well served. In the medical 
research field, invention, development, testing, and publishing may 
serve the individual who has published; however, the medical public 
is not served until such devices prove financially practicable, are 
manufactured, and become readily available to the end user. The 
device or product must also provJde ~ -pr-ofit to the -manufacturer. 
I 
"' 1L .• 
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NEEDS AND RECOMMENDATIONS 
Encourage closer and more effective Interaction between 
physicians, scientists, and engineers during the development 
of innovative technology. This could be enhanced by 
encouraging proposals from engineers In areas of technologic 
need and by recommending medical consultants to the engi-
neers. 
II 
Develop funding Incentives which will encourage the use of 
cost effective technologies. 
Ill 
Encourage the development of standards which wi II meet 
medical needs and at the same time stimulate industry to 
build better and more cost effective Instruments. Assist 
Industry with expedited product approval by the regulatory 
agency (FDA) for devices or products which have a high 
priority, such as those recommended by this task force. 
\ 
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EVALUATIO~ OF TECHNOLOGY 
INTRODUCTION 
It has only been in recent years that medicine has taken a careful 
look at evaluation of the effects of new methods and technologies. 
Development of methodologies for evaluating the effect of a new technology 
is severely lacking. Evaluations typically require complex experimental 
designs and raise ethical and moral questions. For example, if a new 
method is shown to be somewhat effective, is it ethically right to deny 
that technology or methodology tc all patients? If one finds a study 
patient who may be severely compromised when conducting such an 
evaluation, Is one justified In carrying on the experiment just for data 
collection reasons? Evaluation is a very Important, yet very complex, 
procedure. Excellent quantitative and scientific help is needed to solve 
the problems of performing evaluation. 
STATE OF KNOWLEDGE AND TECHNOLOGY 
The number and complexity of test procedures for diagnosing pulmonary 
dysfunction and controlling therapy are rapidly increasing. Unfortunately, 
good studies to evaluate the usefulness of such tests are few. Drugs 
and other therapeutic modalities have legal requirements for efficacy 
testing and liberal support is available for such studies. Determination 
of the effectiveness of diagnostic tests should also be a requirement. 
The lack of such a requirement leads to a dual deficit: 1) the potential 
usefulness of the test may not be realized; and 2) it may be inappropriately 
used, placing patients at undue risk and discomfort and resulting in 
a wasting of resources. A requirement of a II such studies should be 
a true cost analysis so that the providers and sponsors of health care 
can measure the usefulness sgainst cost, not charges. Since the respira-
tory system has a relatively long time constant of change, such studies 
should also assess the optimum frequency for testing. 
Several examples of the problems engendered oy the lack of proper 
evaluation of cost effectiveness or cost- benefit ana lysis of testing patients 
with pulmonary disease wi II illustrate the problerr.. Routine admission 
examinations for most hospitaized patients include hematologic, urinary, 
and blood chemistry analyses, and in some -instances., a ··chest x-ray. 
These tests are done regardless of indication. Yet, few hospitals _car.ry 
out routine simple spirometry, even on high-risk patients who are 
to have major surgical procedures, despite the fact that unrecognized 
pulmonary disease results in a significant incidence of serious preventable 
postoper-ative pulmonary complk.ations. Routine -simple spirometry is 
not widely used because: 1) present technology with automation to 
s1mpllfy testing and interpretation has been underutilized; 2} -charges 
have been set far above costs; and~) physicians have not been educated 
to use this information. 
In contrast, testing for staging carcinoma of the lung is a good example 
of overuti II zation. A number of studies have shown that routine radio-
isotope scanning procedures for determining tumor spread--bone, brain, 
~- . 
and liver scans--are of no value in asymptomatic patients (2, 5}. However, 
these tests are used routinely by many in all patients with carcinoma. 
Computed tomography is now being added to the tests without critical 
evaluation of its usefulness. 
Detailed in the ICU/anesthesiology section of this chapter is the efficacy 
of the measurement of end-tidal C0.2. Its usefulness in the ICU, although 
very promising, is untested; yet, rnrge sums of money are being spent 
for complex instrument systems to monitor airway CO concentrations 
(1 ,6, 7}. These examples of monitoring, routine testihg, and disease 
specific testing are cited to emphasize the fact that for all kinds of 
tests of pulmonary disease, objective studies of appropriateness are 
lacking. Definitive multi-institutional studies to determine test effectiveness 
wi II allow PSRO review to be more precise and protect those physicians 
not doing unnecessary tests from the risk of malpractice. It is now 
national policy to carry out institutional appropriateness review. It 
should be national policy to carry out technology appropriateness studies. 
Other areas where evaluations are needed are outlined below. 
Respiratory Gas Analysis 
The potential of mass spectrometers for measuring cardiac output 
noninvasively needs further evaluation. This evaluation should 
include assessment of the accuracy, reliability, and technical skill 
needed for making this measurem~nt; in particular, the physiologic 
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and clinical situations in which tHe measurement is unreliable need 
definition. A further aspect of this study is to assess the nonin-
vasive measurement against that provided by Swan-Ganz catheterization. 
Does the added information (filling pressures, mixed venous samples} 
provided by the Swan-Ganz catheter outweigh the consideration 
of invasiveness? 
· The incremental benefit of gas analysis over simple airflow and 
pressure monitoring needs to be studied. 
.. 
Instruments for continuously measuring oxygen consumption and 
carbon dioxide production are in the prototype stage. These instru-
ments need to be evaluated not only for reliability, but more importantly, 
to assess the usefulness of these measurements in managing patients. 
Respirators 
· In spite of the advantages claimed for intermittent mandatory venti-
lation ... controlled ventilation .is .still widely .used. A systematic 
comparison of these two forms of ventilation should be performed. 
· High frequency positive pressure ventilation {HFPPV ~ or jet venti-
lation} has been used in a limited way in Europe and in some centers 
in the United States. The use of this form of ventilation should 
be investigated, particularly in conditions where high levels of 
PEEP or CPAP are to be avoided, such as head injury. The effect 
of this form of therapy on traditional forms of respiratory monitoring 
will likewise need evaluation. 
• 
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An area of medicine which has recently received much attention and 
evaluation is computed tomography (3). Methodologies have been devel-
oped using receiver operator curves (ROC) to help determine which 
competing diagnostic method is better (4). The ROC method works 
well if sufficient cases of proven positive and proven negative diagnoses 
are available and if a confirmatory "reference" diagnostic test is available. 
Methods for evaluating cost effectiveness are also becoming available (8). 
NEEDS AND RECOMMENDATONS 
Establish methodologies for conducting evaluations on various 
technologies. This has already begun but could be accelerated 
by long-term funding commitments through agencies such as 
the National Center for Health Care Technology. 
II 
Multi-institution studies should be conducted to assess the 
effectiveness of various technologies. 
Though some applications of technology may be effective 
for one situation, they may be completely Inappropriate for 
other uses. Therefore, It is Important to outline the boundaries 
of appropriate technological development. A review of high cost 
technologies, whether because of high cost of a single test or 
multiple low cost tests, should be conducted. 
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